What Is Quality 4.0?

Revolutionise Quality Through Quality 4.0

Quality 4.0 and Industry 4.0

Our industry is moving towards the factory of the future. Massive gains in process insight, efficiency and control can be made through the digitisation of the workplace, but what rewards can the quality department expect to reap? Well, there are many!

Industry 4.0, also know as the fourth industrial revolution, is a well-established term that is gathering more momentum by the minute. But you might be pleasantly surprised to learn that ‘Quality 4.0’ is a phrase that is also set to begin making headways soon enough, too.

What exactly is Quality 4.0? 

Quality 4.0 refers to the future of quality management through the adoption of emerging technologies in the context of Industry 4.0, in order to achieve operational excellence. The quality-driven revolution is powered by the shift to a digital way of working within the manufacturing industry, leading to greater robustness and efficiency in our processes.

The pillars of Quality 4.0

 

Quality 4.0 Tools

A number of tools have been identified as key technologies that can be used to enable companies to ensure Quality 4.0. Examples of these tools include;

  • Artificial Intelligence
  • Machine Learning 
  • Big Data 
  • Cloud Computing
  • Virtual Reality (VR)
However, Quality 4.0 is much more than just technology, but a commitment to a culture of quality. These industry 4.0 technologies aid companies in following the modern path to digital transformation and optimising quality processes.
 

Why Use Quality 4.0?

For many companies, paper-based tasks and systems are still commonplace. To date, most of the data management processes in Quality Assurance (QA) and Quality Control (QC) departments follow a paper-based workflow. Using antiqued techniques to maintain critical quality records requires numerous manual checks to ensure data integrity and product quality standards are met. Such systems are time-consuming, prone to human error, and are vulnerable to data loss through inadequate storage solutions over time.

Recent process analytical technologies (PAT) can be incorporated into your process to offer in-line quality measures that modernise QA, digitise QC laboratories, and eliminate the need for paper-based systems. When taken one step further with a fully automated control system, data can be captured and interoperated in real-time, shared with the broader team for review, or safely archived for ease of future retrieval. In this way, a general push to Industry 4.0 results in the removal of steps that are not value add, while strengthening quality standards along the way.

Revolutionise Quality Through Quality 4.0

 

Digitise Your Process To Become Quality 4.0 Focused

In high-volume environments, manual quality inspections are costly and slow. To assess particle size in bulk solids, you would typically carry out sampling inspection, which involves determining the quality of an entire production batch by analysing a small portion of the product at a time. This step is classically performed by sieve analysis or other at-line methods to determine particle size distribution (PSD). Particle size analysers such as Eyecon2 offer an evolutionary leap by continuously measuring in-line particle size to enable the automation of inspection.

The benefits of AI in pharma manufacturing come into play here, as the adoption of real-time, analytical technologies supports us in building the factory of the future. With powerful insights, we can avail of many more quality-focused boons such as the enablement of Continuous Process Verification (CPV). CPV is the activity that provides ongoing verification of a manufacturing process’ performance and is founded on the principle of using process knowledge to demonstrate that the process is validated. Process knowledge such as real-time particle size data can be captured dynamically from PAT, like Eyecon2. CPV is a necessity for the ultimate goal of Real-Time Release Testing, a much sought after target that reduces overheads and generates more efficient workloads.

 

Smart Factory starts with Quality 4.0

Quality 4.0 is part of the journey to the Smart Factory, where digital processes increase productivity and flexibility from the factory floor right up to the wider enterprise. Digital technologies enhance quality by giving companies powerful tools that allow them to monitor processes and collect data in real-time, apply analytics, and predict quality issues. These tools offer the assurance to become proactive rather than reactive in the approach to quality. A combination of automated digital tools like Eyecon2 and a governing control system facilitates factories to produce faster and better products at reduced costs.

To learn more about how Eyecon2 and advanced control systems can propel you to Quality 4.0, get in touch with us!

At Innopharma Technology, we are driven to push the boundaries of industry and share our knowledge. Follow us on LinkedIn and Twitter for more exciting developments from trailblazing R&D to Industry 4.0!

Chris O’Callaghan

Chris O’Callaghan is Head of Engineering within Innopharma Technology and is responsible for process analytical technologies and control products, applications development, and customer project delivery. He and his team manage the custom engineering projects required to successfully interface control systems with new and existing product lines in the continuous and batch manufacturing spaces, as well as control strategy development and deployment.

Caroline McCormack

Caroline McCormack is a Process Scientist working at Innopharma Technology and supports a number of ongoing R&D projects. She is responsible for experimentation around our process analytical technologies and advanced process control techniques currently in development, across the batch and continuous oral solid dose manufacturing space.

Eyecon₂ Direct Imaging Particle Analyser 

Uses direct imaging processed in real-time, with ellipses fitted to each particles boundary, shape and size reported back, highlighting variations

 

Pharma Industry Awards 2021 Proud Sponsor

Caroline McCormack

Caroline McCormack is a Process Scientist working at Innopharma Technology and supports a number of ongoing R&D projects. She is responsible for experimentation around our process analytical technologies and advanced process control techniques currently in development, across the batch and continuous oral solid dose manufacturing space.

Caroline McCormack

Caroline McCormack is a Process Scientist working at Innopharma Technology and supports a number of ongoing R&D projects. She is responsible for experimentation around our process analytical technologies and advanced process control techniques currently in development, across the batch and continuous oral solid dose manufacturing space.

Caroline McCormack

Caroline McCormack is a Process Scientist working at Innopharma Technology and supports a number of ongoing R&D projects. She is responsible for experimentation around our process analytical technologies and advanced process control techniques currently in development, across the batch and continuous oral solid dose manufacturing space.

Caroline McCormack

Caroline McCormack is a Process Scientist working at Innopharma Technology and supports a number of ongoing R&D projects. She is responsible for experimentation around our process analytical technologies and advanced process control techniques currently in development, across the batch and continuous oral solid dose manufacturing space.